Ranitidine Versus Colloidal Bismuth Subcitrate in Combination with Amoxicillin and Metronidazole for Eradicating Helicobacter pylori in Patients with Duodenal Ulcer

作者: Pedro Carpintero , Margarita Blanco , Jose Maria Pajares

DOI: 10.1086/516084

关键词:

摘要: One hundred twenty-two patients were randomly assigned to three groups of treatment (A, B, and C), with (I) ranitidine (300 mg q.d. for 6 weeks), (2) weeks) amoxicillin (500 t.i.d.) metronidazole b.i.d.) the first 12 days, or (3) colloidal bismuth subcitrate (120 q.i.d. (at same dosages as in latter group). Six weeks after beginning treatment, an endoscopy showed that ulcers had healed 49 52 (94.2%) from whom Helicobacter pylori been eradicated 59 70 (84.3%) it not (NS). The rates H. eradication A, C zero, 47.5%, 86.8%, respectively. At 6, 12, 18 months, was repeated monitoring ulcer recurrence status. Reinfection at months 42.1% 15.1% B C, respectively (P <.05). recurred 82.9% (63) 76 noneradicated infection, vs. 5.7% 35 without infection <.001). We conclude is more effective than when given plus duodenal ulcer, both early reinfection are diminished.

参考文章(25)
P Sipponen, K Varis, H R Nevanlinna, P Sistonen, M Siurala, M Kekki, Classification principles and genetics of chronic gastritis. Scandinavian Journal of Gastroenterology. ,vol. 141, pp. 1- 28 ,(1987)
G. Bianchi Porro, M. Petrillo, C. De Nicola, M. Lazzaroni, A double-blind endoscopic study with De-Nol tablets and cimetidine for duodenal ulcer. Scandinavian Journal of Gastroenterology. ,vol. 19, pp. 905- 908 ,(1984) , 10.1080/00365521.1984.12005830
Shiann Pan, Chen-Hsuing Liao, Gi-Shih Lien, Sheng-Hsuan Chen, Histological maturity of healed duodenal ulcers and ulcer recurrence after treatment with colloidal bismuth subcitrate or cimetidine. Gastroenterology. ,vol. 101, pp. 1187- 1191 ,(1991) , 10.1016/0016-5085(91)90066-T
John H. Kurata, Gary G. Koch, Aki N. Nogawa, Comparison of ranitidine and cimetidine ulcer maintenance therapy. Journal of Clinical Gastroenterology. ,vol. 9, pp. 644- 650 ,(1987) , 10.1097/00004836-198712000-00007
BarryJ Marshall, J Robin Warren, ElizabethD Blincow, Michael Phillips, C Stewart Goodwin, Raymond Murray, StephenJ Blackbourn, ThomasE Waters, ChristopherR Sanderson, None, Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. The Lancet. ,vol. 332, pp. 1437- 1442 ,(1988) , 10.1016/S0140-6736(88)90929-4
S Patchett, S Beattie, E Leen, C Keane, C O'Morain, Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia. BMJ. ,vol. 303, pp. 1238- 1240 ,(1991) , 10.1136/BMJ.303.6812.1238
G. D. BELL, K. POWELL, S. M. BURRIDGE, A. PALLECAROS, P. H. JONES, P. W. GANT, G. HARRISON, J. E. TROWELL, Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Alimentary Pharmacology & Therapeutics. ,vol. 6, pp. 427- 435 ,(2007) , 10.1111/J.1365-2036.1992.TB00556.X
D Armstrong, R Arnold, M Classen, M Fischer, H Goebell, A L Blum, Prospective multicentre study of risk factors associated with delayed healing of recurrent duodenal ulcers (RUDER). RUDER Study Group. Gut. ,vol. 34, pp. 1319- 1326 ,(1993) , 10.1136/GUT.34.10.1319
J.G. Coghlan, H. Humphries, C. Dooley, C. Keane, D. Gilligan, D. Mckenna, E. Sweeney, C. O'Morain, CAMPYLOBACTER PYLORI AND RECURRENCE OF DUODENAL ULCERS— A 12-MONTH FOLLOW-UP STUDY The Lancet. ,vol. 330, pp. 1109- 1111 ,(1987) , 10.1016/S0140-6736(87)91545-5